Cyclooxygenase 3 Inhibition: A Probable Mechanism of Acetaminophen in Human: A Review

Authors

  • Iswar Hazarika Department of Pharmacology, T John College of Pharmacy, Gottigere, Bannerghatta Road, Bangalore, Karnataka, India
  • Panner Selvam Department of Pharmacology, T John College of Pharmacy, Gottigere, Bannerghatta Road, Bangalore, Karnataka, India

DOI:

https://doi.org/10.37591/(rrjops).v6i3.517

Abstract

 

The key rate-limiting step in prostanoid and thromboxane biosynthesis is catalyzed by Cyclooxygenases (COXs) and is the target of nonsteroidal anti-inflammatory drugs (NSAIDs). Until recently, the existence of only two isoforms: COX-1 and COX-2; remained under debate as the anti-pyretic and analgesic property of acetaminophen (paracetamol) could not be explained by mere COX-1 or COX-2 blockades. A novel COX-1 splice variant termed COX-3, sensitive to acetaminophen, was recently discovered in dog brain by Simmons et al., and is considered to play a major role in the biosynthesis of prostanoids known to be significant mediators in pain and fever. Drugs that preferentially block COX-1 also appear to act at COX-3. However at the nucleotide sequence level in humans, the existence of COX-3 is questionable. A functional COX-3 in humans is still perplexing, underlining that the concept of COX-3 is still attractive.

 

Keywords: COX, NSAIDs, acetaminophen

Cite this Article

Iswar Hazarika, Panner Selvam. Cyclooxygenase 3 inhibition: a probable mechanism of acetaminophen in human: A review. Research & Reviews: A Journal of Pharmaceutical Science. 2015; 6(3): 23–29p.

Downloads

Published

2019-07-09

Issue

Vol. 6 No. 3 (2015)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.